France · Source-listed medicine information
France / CIS 68406840
CHLORHEXIDINE/BENZALKONIUM/ALCOOL BENZYLIQUE VIATRIS CONSEIL 0,25 g/0,025 g/4 mL pour 100 mL, solution pour application locale
solution pour application · cutanée
Source data retrieved: 2026-09-17. Clinical review is not yet available.
Product identity
At a glance
- Authorisation holder
- VIATRIS SANTE
- Authorisation status
- Autorisation active
- Market status
- Commercialisée
- Country
- France
- Source reference
- CIS 68406840
Reported market status does not confirm current pharmacy stock.
From the official composition record
Ingredients & strength
Source entries are shown individually. An active substance (SA) and its reference moiety (FT) may describe the same ingredient; do not add their strengths together.
| Ingredient | Strength / reference | Source role |
|---|---|---|
| ALCOOL BENZYLIQUEsolution | 4,000 ml100 ml | SAGroup 4 |
| GLUCONATE DE CHLORHEXIDINEsolution | 0,250 g100 ml | SAGroup 1 |
| CHLORURE DE BENZALKONIUMsolution | 0,025 g100 ml | SAGroup 3 |
Pack references
Presentations (1)
CIP13 3400930185360
Présentation active · Déclaration de commercialisationFrom the French medicines authority
Official documents
The official product entry provides access to the patient leaflet and professional product information when available. Documents are in French and availability varies by medicine.
Open the official product entryBDPM · CIS 68406840 · Opens in a new tabCheck the medicine name, strength and form against your pack. The authority’s current documents may be newer than the catalogue snapshot shown here.
Where this information comes from
Sources & dates
Base de données publique des médicaments (BDPM), France. Retrieval dates record when we obtained the source files; they are not clinical review dates or a guarantee of current stock.
| Source file | Retrieved | Source file modified |
|---|---|---|
| fr_products.txt | Not supplied | |
| fr_composition.txt | Not supplied | |
| fr_packs.txt | Not supplied |
Directory source checks cover the factual catalogue record.Molindra clinical guidance has not yet been reviewed or published for this medicine.
Our sources and review process →